Spearman correlation analysis showed that serum LDH, MIA, and S-100B levels were positively linked to the clinical stage (all P < 0.05), suggesting that the elevation of serum LDH, MIA, and S-100B may be related to tumor progression. Here, S100B is linked to neoplasm.